What Happened?
Radnor, PA-based Mineralys-Therapeutics Appointed Jon Congleton as Chief Executive Officer
About the Company
At Mineralys Therapeutics we aim to redefine hypertension diagnosis, management and treatment. We are driven to break the “trial and failure” approach to hypertension management and bring a personalized approach to the management of hypertension.
About the Person
Jon Congleton is Chief Executive Officer at Mineralys Therapeutics. Previously, Jon held various senior HR leadership roles in the industry.
Info Source
News
Short Profile